The effects of neoadjuvant and adjuvant chemotherapy on the surgical outcomes of breast reconstruction

Journal of Plastic, Reconstructive and Aesthetic Surgery

Volumn 65, Issue 10, 2012, Pages

  Oh, Eugene ^a   Chim, Harvey ^a   Soltanian, Hooman T ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biologic; Breast cancer; Breast reconstruction; Chemotherapy; Hormonal

Indexed keywords

ANASTROZOLE; BEVACIZUMAB; BLEOMYCIN; CAPECITABINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; EXEMESTANE; FLUOROURACIL; GEMCITABINE; LAPATINIB; LETROZOLE; LEUPRORELIN; METHOTREXATE; PACLITAXEL; RALOXIFENE; TAMOXIFEN CITRATE; TRASTUZUMAB; VINBLASTINE;

ABDOMINAL PAIN; ACNE; ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ALOPECIA; ANEMIA; ANGIONEUROTIC EDEMA; ARTHRITIS; BACKACHE; BONE MARROW SUPPRESSION; BONE PAIN; BREAST CANCER; BREAST RECONSTRUCTION; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHOSPASM; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CARDIOMYOPATHY; CARDIOTOXICITY; CELLULITIS; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CHILL; CHOLESTASIS; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; CORONARY ARTERY SPASM; COUGHING; CREATININE BLOOD LEVEL; DEEP INFERIOR EPIGASTRIC PERFORATOR FLAP; DEEP VEIN THROMBOSIS; DIARRHEA; DIGESTIVE SYSTEM PERFORATION; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DYSPNEA; ECHOCARDIOGRAPHY; EDEMA; ELECTROLYTE DISTURBANCE; ENDOMETRIUM CANCER; FAT NECROSIS; FATIGUE; FRACTURE; GASTROINTESTINAL HEMORRHAGE; GLOMERULONEPHRITIS; GRACILIS FLAP; GRAFT FAILURE; GRAFT NECROSIS; HAIR DISEASE; HEART FAILURE; HEART INFARCTION; HEART INJURY; HEART MUSCLE BIOPSY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICULOGRAPHY; HEPATOBILIARY DISEASE; HOT FLUSH; HUMAN; HYPERCALCEMIA; HYPERTENSION; HYPERTRANSAMINASEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOTENSION; INTERSTITIAL PNEUMONIA; JAUNDICE; KIDNEY INJURY; LATISSIMUS DORSI FLAP; LEUKOPENIA; LIVER CIRRHOSIS; LIVER INJURY; LIVER TOXICITY; LUNG EMBOLISM; LUNG FIBROSIS; LUNG HEMORRHAGE; MASTECTOMY; MUCOSA INFLAMMATION; MYOCARDITIS; NAUSEA; NEUTROPENIA; NOSE SEPTUM PERFORATION; OSTEOPOROSIS; PANCYTOPENIA; PNEUMONIA; PREMENOPAUSE; PRIORITY JOURNAL; PROTEINURIA; REVIEW; SEROMA; SIDE EFFECT; SKIN EXFOLIATION; SKIN NECROSIS; STOMATITIS; STROKE; SUPERFICIAL INFERIOR EPIGASTRIC ARTERY FLAP; SURGICAL INFECTION; SYNCOPE; SYSTEMIC THERAPY; THROMBOEMBOLISM; TRANSVERSE RECTUS ABDOMINIS MUSCULOCUTANEOUS FLAP; TREATMENT OUTCOME; UREMIA; VAGINA BLEEDING; VAGINA DISCHARGE; VISUAL DISORDER; WEIGHT GAIN; WOUND DEHISCENCE; WOUND HEALING IMPAIRMENT;

ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; GRAFT REJECTION; HORMONE REPLACEMENT THERAPY; HUMANS; MAMMAPLASTY; MASTECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; POSTOPERATIVE CARE; PROGNOSIS; RISK ASSESSMENT; WOUND HEALING;

EID: 84866348818     PISSN: 17486815     EISSN: 18780539     Source Type: Journal    
DOI: 10.1016/j.bjps.2012.04.053     Document Type: Review

References (86)

1. R.W. Carlson, C.A. Hudis, and K.I. Pritchard Adjuvant endocrine therapy in hormone receptor-positive postmenopausal breast cancer: evolution of NCCN, ASCO, and St Gallen recommendations J Natl Compr Canc Netw 4 2006 971 979
2. S. Chia, S.M. Swain, D.R. Byrd, and D.A. Mankoff Locally advanced and inflammatory breast cancer J Clin Oncol 26 2008 786 790
3. J.S. Mieog, J.A. van der Hage, and C.J. van de Velde Preoperative chemotherapy for women with operable breast cancer Cochrane Database Syst Rev 2 2007 CD005002
4. S. Dawood, S.D. Merajver, and P. Viens International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment Ann Oncol 22 2011 515 523
5. M. Kaufmann, M. Morrow, G. von Minckwitz, and J.R. Harris Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel Cancer 116 2010 1184 1191
6. C.W. Taylor, K. Horgan, and D. Dodwell Oncological aspects of breast reconstruction Breast 14 2005 118 130
7. M. Kaufmann, G. von Minckwitz, and H.D. Bear Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006 Ann Oncol 18 2007 1927 1934
8. C. Shannon, S. Ashley, and I.E. Smith Does timing of adjuvant chemotherapy for early breast cancer influence survival? J Clin Oncol 21 2003 3792 3797
9. R.W. Carlson, E. Brown, and H.J. Burstein NCCN task force report: adjuvant therapy for breast cancer J Natl Compr Canc Netw 4 Suppl 1 2006 S1 S26
10. T.B. Bevers, B.O. Anderson, and E. Bonaccio NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis J Natl Compr Canc Netw 7 2009 1060 1096
11. D.C. Allred, R.W. Carlson, and D.A. Berry NCCN task force report: estrogen receptor and progesterone receptor testing in breast cancer by immunohistochemistry J Natl Compr Canc Netw 7 Suppl 6 2009 S1 S21 quiz S22-23
12. B.F. Cole, R.D. Gelber, S. Gelber, A.S. Coates, and A. Goldhirsch Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis Lancet 358 2001 277 286
13. E.H. Romond, E.A. Perez, and J. Bryant Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 2005 1673 1684
14. E.A. Perez, E.H. Romond, and V.J. Suman Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31 J Clin Oncol 29 2011 3366 3373
15. I. Smith, M. Procter, and R.D. Gelber 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial Lancet 369 2007 29 36
16. M. Untch, R.D. Gelber, and C. Jackisch Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial Ann Oncol 19 2008 1090 1096
17. G.N. Hortobagyi Comprehensive management of locally advanced breast cancer Cancer 66 1990 1387 1391
18. A. Ardavanis, A. Scorilas, and D. Tryfonopoulos Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and fluorouracil chemotherapy, surgery, and radiotherapy: long-term results Oncologist 11 2006 563 573
19. M. Kaufmann, G.N. Hortobagyi, and A. Goldhirsch Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update J Clin Oncol 24 2006 1940 1949
20. R. Finkel, M.A. Clark, and L.X. Cubeddu Pharmacology 4th ed. 2009 Lippincott Williams & Wilkins Philadelphia
21. K. Azzawi, A. Ismail, H. Earl, P. Forouhi, and C.M. Malata Influence of neoadjuvant chemotherapy on outcomes of immediate breast reconstruction Plast Reconstr Surg 126 2010 1 11
22. K. Chatterjee, J. Zhang, N. Honbo, and J.S. Karliner Doxorubicin cardiomyopathy Cardiology 115 2010 155 162
23. R. Shapiro, D. Barsuk, and L. Segev Pre-operative cardiac workup after anthracycline-based neoadjuvant chemotherapy. Is it really necessary? Ann R Coll Surg Engl Nov 18 2010
24. J.L. Speyer, M.D. Green, and E. Kramer Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer N Engl J Med 319 1988 745 752
25. M.D. Cheitlin, W.F. Armstrong, and G.P. Aurigemma ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American heart association task force on practice guidelines (ACC/AHA/ASE Committee to update the 1997 guidelines for the clinical application of Echocardiography) Circulation 108 2003 1146 1162
26. L.K. Shoemaker, and U. Arora Rocha Lima CM. 5-fluorouracil-induced coronary vasospasm Cancer Control. 11 2004 46 49
27. M.K. Erol, M. Acikel, and H. Senocak Non-Q-wave acute anterior myocardial infarction associated with 5-fluorouracil and cisplatin chemotherapy South Med J 96 2003 99
28. S.E. Rossi, J.J. Erasmus, H.P. McAdams, T.A. Sporn, and P.C. Goodman Pulmonary drug toxicity: radiologic and pathologic manifestations Radiographics 20 2000 1245 1259
29. R.K. Ramanathan, V.V. Reddy, J.M. Holbert, and C.P. Belani Pulmonary infiltrates following administration of paclitaxel Chest 110 1996 289 292
30. G. Ostoros, A. Pretz, J. Fillinger, I. Soltesz, and B. Dome Fatal pulmonary fibrosis induced by paclitaxel: a case report and review of the literature Int J Gynecol Cancer 16 Suppl. 1 2006 391 393
31. H. Zachariae, H. Sogaard, and L. Heickendorff Methotrexate-induced liver cirrhosis. Clinical, histological and serological studies-a further 10-year follow-up Dermatology 192 1996 343 346
32. P.E. Kintzel Anticancer drug-induced kidney disorders Drug Saf 24 1 Jan 2001 19 38
33. V. Launay-Vacher, J.B. Rey, C. Isnard-Bagnis, G. Deray, and M. Daouphars Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of clinical pharmacy special interest group on cancer Care Cancer Chemother Pharmacol 61 2008 903 909
34. M.G. Shah, and H.I. Maibach Estrogen and skin. An overview Am J Clin Dermatol 2 2001 143 150
35. M. Baum, A.U. Budzar, and J. Cuzick Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial Lancet 359 2002 2131 2139
36. J.M. Dixon, J. Jackson, L. Renshaw, and W.R. Miller Neoadjuvant tamoxifen and aromatase inhibitors: comparisons and clinical outcomes J Steroid Biochem Mol Biol 86 2003 295 299
37. A.U. Buzdar, J.P. Guastalla, J.M. Nabholtz, J. Cuzick, and A.T. Group Impact of chemotherapy regimens prior to endocrine therapy: results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial Cancer 107 2006 472 480
38. S.M. Wiseman, N. Makretsov, and T.O. Nielsen Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival Cancer 103 2005 1770 1777
39. L.S. Rosen, H.L. Ashurst, and L. Chap Targeting signal transduction pathways in metastatic breast cancer: a comprehensive review Oncologist 15 2010 216 235
40. A. Seidman, C. Hudis, and M.K. Pierri Cardiac dysfunction in the trastuzumab clinical trials experience J Clin Oncol 20 2002 1215 1221
41. E.A. Perez, M. Koehler, J. Byrne, A.J. Preston, E. Rappold, and M.S. Ewer Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials Mayo Clin Proc 83 2008 679 686
42. H.A. Burris 3rd, H.I. Hurwitz, and E.C. Dees Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas J Clin Oncol 23 2005 5305 5313
43. C.F. Spraggs, L.R. Budde, and L.P. Briley HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer J Clin Oncol 29 2011 667 673
44. J.P. Erinjeri, A.J. Fong, N.E. Kemeny, K.T. Brown, G.I. Getrajdman, and S.B. Solomon Timing of administration of bevacizumab chemotherapy affects wound healing after chest wall port placement Cancer 117 2011 1296 1301
45. K. Miller, M. Wang, and J. Gralow Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer N Engl J Med 357 2007 2666 2676
46. H.X. Chen, and J.N. Cleck Adverse effects of anticancer agents that target the VEGF pathway Nat Rev Clin Oncol 6 2009 465 477
47. A.K. Alderman, E.D. Collins, and A. Schott The impact of breast reconstruction on the delivery of chemotherapy Cancer 116 2010 1791 1800
48. T. Zhong, S.O. Hofer, D.R. McCready, L.M. Jacks, F.E. Cook, and N. Baxter A comparison of surgical complications between immediate breast reconstruction and mastectomy: the impact on delivery of chemotherapy-an analysis of 391 procedures Ann Surg Oncol Jul 27 2011 [Epub ahead of print]
49. P.C. Furey, D.C. Macgillivray, C.L. Castiglione, and L. Allen Wound complications in patients receiving adjuvant chemotherapy after mastectomy and immediate breast reconstruction for breast cancer J Surg Oncol 55 1994 194 197
50. C.M. Malata, S.A. McIntosh, and A.D. Purushotham Immediate breast reconstruction after mastectomy for cancer Br J Surg 87 2000 1455 1472
51. S.J. Kronowitz Immediate versus delayed reconstruction Clin Plast Surg 34 2007 39 50
52. O. Caffo, D. Cazzolli, and A. Scalet Concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expanders after mastectomy for breast cancer Breast Cancer Res Treat 60 2000 267 275
53. J. Johansen, J. Overgaard, and M. Overgaard Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation Acta Oncol 46 2007 525 533
54. D.N. Danforth Jr., M.E. Lippman, and H. McDonald Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer Am Surg 56 1990 6 11
55. M.R. Sertoli, P. Bruzzi, and P. Pronzato Randomized cooperative study of perioperative chemotherapy in breast cancer J Clin Oncol 13 1995 2712 2721
56. E.A. Gonzalez, E.C. Saltzstein, C.S. Riedner, and B.K. Nelson Seroma formation following breast cancer surgery Breast J 9 2003 385 388
57. P.M. Godfrey, N.V. Godfrey, and M.C. Romita Immediate autogenous breast reconstruction in clinically advanced disease Plast Reconstr Surg 95 1995 1039 1044
58. M.R. Sultan, M.L. Smith, A. Estabrook, F. Schnabel, and D. Singh Immediate breast reconstruction in patients with locally advanced disease Ann Plast Surg 38 1997 345 349 discussion 350-341
59. M.F. Deutsch, M. Smith, B. Wang, N. Ainsle, and M.A. Schusterman Immediate breast reconstruction with the TRAM flap after neoadjuvant therapy Ann Plast Surg 42 1999 240 244
60. J. Mitchem, D. Herrmann, J.A. Margenthaler, and R.L. Aft Impact of neoadjuvant chemotherapy on rate of tissue expander/implant loss and progression to successful breast reconstruction following mastectomy Am J Surg 196 2008 519 522
61. A. Banic, W. Boeckx, and M. Greulich Late results of breast reconstruction with free TRAM flaps: a prospective multicentric study Plast Reconstr Surg 95 1995 1195 1204 discussion 1205-1196
62. C.M. McCarthy, B.J. Mehrara, and E. Riedel Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk Plast Reconstr Surg 121 2008 1886 1892
63. M. Zweifel-Schlatter, N. Darhouse, P. Roblin, D. Ross, M. Zweifel, and J. Farhadi Immediate microvascular breast reconstruction after neoadjuvant chemotherapy: complication rates and effect on start of adjuvant treatment Ann Surg Oncol 17 2010 2945 2950
64. B.J. Mehrara, T.D. Santoro, E. Arcilla, J.P. Watson, W.W. Shaw, and A.L. Da Lio Complications after microvascular breast reconstruction: experience with 1195 flaps Plast Reconstr Surg 118 Oct 2006 1100 1109 discussion 1110-1101
65. Y.Y. Hu, C.M. Weeks, and H. In Impact of neoadjuvant chemotherapy on breast reconstruction Cancer 117 2011 2833 2841
66. E. Ruvalcaba-Limon, C. Robles-Vidal, A. Poitevin-Chacon, M. Chavez-Macgregor, C. Gamboa-Vignolle, and D. Vilar-Compte Complications after breast cancer surgery in patients treated with concomitant preoperative chemoradiation: a case-control analysis Breast Cancer Res Treat 95 2006 147 152
67. P.L. Giacalone, G. Rathat, J.P. Daures, P. Benos, D. Azria, and C. Rouleau New concept for immediate breast reconstruction for invasive cancers: feasibility, oncological safety and esthetic outcome of post-neoadjuvant therapy immediate breast reconstruction versus delayed breast reconstruction: a prospective pilot study Breast Cancer Res Treat 122 2010 439 451
68. E.R. Sauter, B.L. Eisenberg, and J.P. Hoffman Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer World J Surg 17 1993 237 241 discussion 242
69. G.S. Ashcroft, J. Dodsworth, and E. van Boxtel Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels Nat Med 3 1997 1209 1215
70. L. Campbell, E. Emmerson, and F. Davies Estrogen promotes cutaneous wound healing via estrogen receptor beta independent of its antiinflammatory activities J Exp Med 207 2010 1825 1833
71. G.S. Ashcroft, T. Greenwell-Wild, M.A. Horan, S.M. Wahl, and M.W. Ferguson Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response Am J Pathol 155 1999 1137 1146
72. M.J. Hardman, E. Emmerson, L. Campbell, and G.S. Ashcroft Selective estrogen receptor modulators accelerate cutaneous wound healing in ovariectomized female mice Endocrinology 149 2008 551 557
73. M.B. Ruffy, S.S. Kunnavatana, and R.J. Koch Effects of tamoxifen on normal human dermal fibroblasts Arch Facial Plast Surg 8 2006 329 332
74. A.A. Mikulec, M.M. Hanasono, J. Lum, J.M. Kadleck, M. Kita, and R.J. Koch Effect of tamoxifen on transforming growth factor beta1 production by keloid and fetal fibroblasts Arch Facial Plast Surg 3 2001 111 114
75. D.J. Howgate, Z. Gamie, P. Panteliadis, A. Bhalla, A. Mantalaris, and E. Tsiridis The potential adverse effects of aromatase inhibitors on wound healing: in vitro and in vivo evidence Expert Opin Drug Saf 8 2009 523 535
76. D. Azria, S. Gourgou, and W.J. Sozzi Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients Br J Cancer 91 2004 1251 1260
77. N.G. Kelessis, P.P. Vassilopoulos, A.V. Galanopoulou, A.G. Nessiotis, and C.M. Stravolemos Administration of tamoxifen in the perioperative period to patients with breast carcinoma prolongs axillary fluid drainage Anticancer Res 20 2000 1245 1248
78. S.E. Appleton, A. Ngan, B. Kent, and S.F. Morris Risk factors influencing transfusion rates in DIEP flap breast reconstruction Plast Reconstr Surg 127 2011 1773 1782
79. P.L. Myskowski, and A.C. Halpern Skin reactions to the new biologic anticancer drugs Curr Opin Support Palliat Care 3 2009 294 299
80. S.B. Wedam, J.A. Low, and S.X. Yang Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer J Clin Oncol 24 2006 769 777
81. C.R. Gordon, Y. Rojavin, and M. Patel A review on bevacizumab and surgical wound healing: an important warning to all surgeons Ann Plast Surg 62 2009 707 709
82. M. Golshan, J.E. Garber, and R. Gelman Does neoadjuvant bevacizumab increase surgical complications in breast surgery? Ann Surg Oncol 18 2011 733 737
83. R.K. Hernandez, H.T. Sorensen, L. Pedersen, J. Jacobsen, and T.L. Lash Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: a Danish population-based cohort study Cancer 115 2009 4442 4449
84. S.J. Kronowitz, C. Lam, and W. Terefe A multidisciplinary protocol for planned skin-preserving delayed breast reconstruction for patients with locally advanced breast cancer requiring postmastectomy radiation therapy: 3-year follow-up Plast Reconstr Surg 127 2011 2154 2166
85. E. Senkus, and J. Jassem Cardiovascular effects of systemic cancer treatment Cancer Treat Rev 37 4 Jun 2011 300 311
86. M.A. Goldberg, J.H. Antin, E.C. Guinan, and J.M. Rappeport Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor Blood 68 5 Nov 1986 1114 1118